Terumo India, the Indian arm of Japan-based Terumo Corporation, has announced the launch of FineGlide, a sterile pen needle for patients requiring regular insulin injections or other self-medication.

Designed to be compatible with the most commonly available pen devices in India, Fineglide raises the bar for patient comfort and thereby, drug compliance.

FineGlide is the first product from the Life Care Solutions division of Terumo Medical Care Solutions to be launched in India. Designed as a 3-bevel super sharp needle with a high-grade silicone surface, Fineglide is gentle and more comfortable for patients. It’s built with Thin Wall Technology to ensure a greater flow rate and provides better penetration requiring lesser injection force when compared with other alternatives in the market.

Compatible with the most commonly available pen devices in India, Fineglide is available in multiple sizes ranging from 4 mm to 12.7 mm in length and 29-32 gauge thickness to suit varied applications.